Cas:71561-11-0 pyrazoxyfen manufacturer & supplier

Chemical Name:pyrazoxyfen

CAS.NO:71561-11-0

Synonyms:2-[[4-(2,4-dichlorobenzoyl)-1,3-dimethyl-1H-pyrazol-5-yl]oxy]-1-phenylethanone;Pyrazoxyfen [ISO:BSI];4-(2,4-dichloro-benzoyl)-1,3-dimethyl-5-(phenyl–carbonylmethoxy)-pyrazole;2-[4-(2,4-dichlorobenzoyl)-2,5-dimethylpyrazol-3-yl]oxy-1-phenylethanone;1,3-dimethyl-4-(2,4-dichlorobenzoyl)-5-phenacyloxypyrazole;2-((4-(2,4-Dichlorobenzoyl)-1,3-dimethyl-1H-pyrazol-5-yl)oxy)-1-phenylethanone;2-[4-(2,4-dichlorobenzoyl)-1,3-dimethylpyrazol-5-yloxy]acetophenone;Paicer;Ethanone,2-((4-(2,4-dichlorobenzoyl)-1,3-dimethyl-1H-pyrazol-5-yl)oxy)-1-phenyl;1,3-dimethyl-4-(2,4-dichlorobenzoyl)-5-(benzoylmethoxy)-pyrazole;SL 49;2-{[4-(2,4-dichlorobenzoyl)-1,3-dimethyl-1H-pyrazol-5-yl]oxy}-1-phenylethan-1-one;2-(4-(2,4-Dichlorobenzoyl)-1,3-dimethylpyrazol-5-yloxy)acetophenone

Molecular Formula:C₂₀H₁₆Cl₂N₂O₃

Molecular Weight:403.25900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:599.9ºC at 760 mmHg

Density:1.33 g/cm3

Index of Refraction:1.618

PSA:61.19000

Exact Mass:402.05400

LogP:4.52800

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3077 9 / PGIII

Packing Group:

Contact us for information like 2-[[4-(2,4-dichlorobenzoyl)-1,3-dimethyl-1H-pyrazol-5-yl]oxy]-1-phenylethanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-(2,4-Dichlorobenzoyl)-1,3-dimethylpyrazol-5-yloxy)acetophenone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pyrazoxyfen [ISO:BSI] Use and application,2-[4-(2,4-dichlorobenzoyl)-1,3-dimethylpyrazol-5-yloxy]acetophenone technical grade,usp/ep/jp grade.

Related News: Results from a Phase I clinical trial, published in The Lancet, found that two-doses of the inhaled Ad5-nCoV vaccine can trigger a similar immune response to a single-dose of the injected version. Pyrimidine, 2,2′-(1,4-phenylene)bis[5-(4-methoxyphenyl)- manufacturers Dr. Elsie Melsopp, Head of Solids Formulations for Alcami, says the company successfully helped a client overcome an API supply shortage using Quality by Design (QbD) studies to successfully formulate an orphan drug product. 4-Nitro-benzenesulfonic acid (R)-3-(3-fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl ester suppliers As Natural Capsules did not have access to this manufacturing technology, its R&D centre, which is DSIR approved, had started working on the same since 2018, and has now successfully developed the process including fermentation and chemical synthesis steps, Sunil Mundra, managing director, Natural Capsules told Pharmabiz. 20-hydroxy-(12β)-9,22-seco-yuzurimin-8-en-23-oic acid lactone vendor & factory.